Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: The effect of bisphosphonate therapy on bone scintigraphy results

By Roudier M.P.   Vesselle H.   True L.D.   Higano C.S.   Ott S.M.   King S.H.   Vessella R.L.  

Clinical and Experimental Metastasis, Vol. 20, Iss. 2, 2003-03 ,pp. : 171-180

Springer Publishing Company

Access to resources Recommend Favorite

Bone loss and the evolving role of bisphosphonate therapy in prostate cancer

By Higano C.S.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 5, 2003-09 ,pp. : 392-398

Elsevier

Access to resources Recommend Favorite

Activin A circulating levels in patients with bone metastasis from breast or prostate cancer

By Leto Gaetano   Incorvaia Lorena   Badalamenti Giuseppe   Tumminello Francesca   Gebbia Nicola   Flandina Carla   Crescimanno Marilena   Rini Giovambattista  

Clinical and Experimental Metastasis, Vol. 23, Iss. 2, 2006-04 ,pp. : 117-122

Springer Publishing Company

Access to resources Recommend Favorite

The Role of Bone Scintigraphy in the Follow-up of Osteogenic Sarcoma

By Korholz D.   Wirtz I.   Vosberg H.   Ruther W.   Jurgens H.   Gobel U.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 461-464

Elsevier

Access to resources Recommend Favorite

Agents Targeting Prostate Cancer Bone Metastasis

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 10, 2009-12 ,pp. : 1079-1088

Bentham Science Publishers

Access to resources Recommend Favorite